Six years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $75 million


Experts say the CEO’s second attempt to buy back the troubled DNA startup comes with a slew of corporate governance red flags. Read More

Related Content

F&O Strategy: Buy 3500-call on TCS

F&O Strategy: Buy 3500-call on TCS

F&O Strategy: Buy 3500-call on TCS

Leave a Comment